Daniele Yumi Sunaga-Franze

Dr. Daniele Yumi Sunaga-Franze

Max Delbrück Center for Molecular Medicine, Berlin, Germany
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2017 in Human Mutation
Verified
Journal Article
Closed access
PDF file
MNMichel Satya Naslavsky
Michel Satya Naslavsky
GYGuilherme Lopes Yamamoto
Guilherme Lopes Yamamoto
TATatiana Ferreira Almeida
Tatiana Ferreira Almeida
SESuzana A. M. Ezquina
Suzana A. M. Ezquina
DSDaniele Yumi Sunaga-Franze
Daniele Yumi Sunaga-Franze
MZMAYANA ZATZ
MAYANA ZATZ

11 November 2014 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
KGK Griesi-Oliveira
K Griesi-Oliveira
AAA Acab
A Acab
AGA R Gupta
A R Gupta
DSDaniele Yumi Sunaga-Franze
Daniele Yumi Sunaga-Franze
TCT Chailangkarn
T Chailangkarn
AMAlysson Muotri
Alysson Muotri
An increasing number of genetic variants have been implicated in autism spectrum disorders (ASDs), and the functional study of such variants will be critical for the elucidation of autism pathophysiology. Here, we report a de novo balanced translocation disruption of TRPC6, a cation channel, in a non-syndromic autistic individual. Using multiple models, such as dental pulp cells, induced pluripotent stem cell (iPSC)-derived neuronal cells and mouse models, we demonstrate that TRPC6 reduction or haploinsufficiency leads to altered neuronal development, morphology and function. The observed neuronal phenotypes could then be rescued by TRPC6 complementation and by treatment with insulin-like growth factor-1 or hyperforin, a TRPC6-specific agonist, suggesting that ASD individuals with alterations in this pathway may benefit from these drugs. We also demonstrate that methyl CpG binding protein-2 (MeCP2) levels affect TRPC6 expression. Mutations in MeCP2 cause Rett syndrome, revealing common pathways among ASDs. Genetic sequencing of TRPC6 in 1041 ASD individuals and 2872 controls revealed significantly more nonsynonymous mutations in the ASD population, and identified loss-of-function mutations with incomplete penetrance in two patients. Taken together, these findings suggest that TRPC6 is a novel predisposing gene for ASD that may act in a multiple-hit model. This is the first study to use iPSC-derived human neurons to model non-syndromic ASD and illustrate the potential of modeling genetically complex sporadic diseases using such cells.

14 February 2020 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
KGK. Griesi-Oliveira
K. Griesi-Oliveira
MFM. S. Fogo
M. S. Fogo
BPB. G. G. Pinto
B. G. G. Pinto
AAA. Y. Alves
A. Y. Alves
ASA. M. Suzuki
A. M. Suzuki
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
Evaluation of expression profile in autism spectrum disorder (ASD) patients is an important approach to understand possible similar functional consequences that may underlie disease pathophysiology regardless of its genetic heterogeneity. Induced pluripotent stem cell (iPSC)-derived neuronal models have been useful to explore this question, but larger cohorts and different ASD endophenotypes still need to be investigated. Moreover, whether changes seen in this in vitro model reflect previous findings in ASD postmortem brains and how consistent they are across the studies remain underexplored questions. We examined the transcriptome of iPSC-derived neuronal cells from a normocephalic ASD cohort composed mostly of high-functioning individuals and from non-ASD individuals. ASD patients presented expression dysregulation of a module of co-expressed genes involved in protein synthesis in neuronal progenitor cells (NPC), and a module of genes related to synapse/neurotransmission and a module related to translation in neurons. Proteomic analysis in NPC revealed potential molecular links between the modules dysregulated in NPC and in neurons. Remarkably, the comparison of our results to a series of transcriptome studies revealed that the module related to synapse has been consistently found as upregulated in iPSC-derived neurons—which has an expression profile more closely related to fetal brain—while downregulated in postmortem brain tissue, indicating a reliable association of this network to the disease and suggesting that its dysregulation might occur in different directions across development in ASD individuals. Therefore, the expression pattern of this network might be used as biomarker for ASD and should be experimentally explored as a therapeutic target.

13 August 2021 in The Plant Journal
Verified
Journal Article
Open access
PDF file
DSDaniele Yumi Sunaga-Franze
Daniele Yumi Sunaga-Franze
JMJose M. Muino
Jose M. Muino
CBCaroline Braeuning
Caroline Braeuning
XXXiaocai Xu
Xiaocai Xu
MZMinglei Zong
Minglei Zong
SSSascha Sauer
Sascha Sauer
SUMMARY: Single‐cell genomics provides unprecedented potential for research on plant development and environmental responses. Here, we introduce a generic procedure for plant nucleus isolation combined with nanowell‐based library preparation. Our method enables the transcriptome analysis of thousands of individual plant nuclei. It serves as an alternative to the use of protoplast isolation, which is currently a standard methodology for plant single‐cell genomics, although it can be challenging for some plant tissues. We show the applicability of our nucleus isolation method by using different plant materials from different species. The potential of our single‐nucleus RNA sequencing method is shown through the characterization of transcriptomes of seedlings and developing flowers from Arabidopsis thaliana. We evaluated the transcriptome dynamics during the early stages of anther development, identified stage‐specific activities of transcription factors regulating this process, and predicted potential target genes of these transcription factors. Our nucleus isolation procedure can be applied in different plant species and tissues, thus expanding the toolkit for plant single‐cell genomics experiments.

12 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GKGerson Shigeru Kobayashi
Gerson Shigeru Kobayashi
LALucas Alvizi
Lucas Alvizi
DSDaniele Yumi Sunaga-Franze
Daniele Yumi Sunaga-Franze
PFPhilippa Francis-West
Philippa Francis-West
AKAnna Kuta
Anna Kuta
MPMaria Rita Passos-Bueno
Maria Rita Passos-Bueno
Non-syndromic cleft lip/palate (NSCL/P) is a complex, frequent congenital malformation, determined by the interplay between genetic and environmental factors during embryonic development. Previous findings have appointed an aetiological overlap between NSCL/P and cancer, and alterations in similar biological pathways may underpin both conditions. Here, using a combination of transcriptomic profiling and functional approaches, we report that NSCL/P dental pulp stem cells exhibit dysregulation of a co-expressed gene network mainly associated with DNA double-strand break repair and cell cycle control (p = 2.88×10 −2 –5.02×10 −9 ). This network included important genes for these cellular processes, such as BRCA1 , RAD51 , and MSH2 , which are predicted to be regulated by transcription factor E2F1. Functional assays support these findings, revealing that NSCL/P cells accumulate DNA double-strand breaks upon exposure to H 2 O 2 . Furthermore, we show that E2f1 , Brca1 and Rad51 are co-expressed in the developing embryonic orofacial primordia, and may act as a molecular hub playing a role in lip and palate morphogenesis. In conclusion, we show for the first time that cellular defences against DNA damage may take part in determining the susceptibility to NSCL/P. These results are in accordance with the hypothesis of aetiological overlap between this malformation and cancer, and suggest a new pathogenic mechanism for the disease.

1 November 2012 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
RPRenata Pellegrino
Renata Pellegrino
DSDaniele Yumi Sunaga-Franze
Daniele Yumi Sunaga-Franze
CGC. Guindalini
C. Guindalini
RMR. C. S. Martins
R. C. S. Martins
DMD. R. Mazzotti
D. R. Mazzotti
STS. Tufik
S. Tufik
Although the specific functions of sleep have not been completely elucidated, the literature has suggested that sleep is essential for proper homeostasis. Sleep loss is associated with changes in behavioral, neurochemical, cellular, and metabolic function as well as impaired immune response. Using high-resolution microarrays we evaluated the gene expression profiles of healthy male volunteers who underwent 60 h of prolonged wakefulness (PW) followed by 12 h of sleep recovery (SR). Peripheral whole blood was collected at 8 am in the morning before the initiation of PW (Baseline), after the second night of PW, and one night after SR. We identified over 500 genes that were differentially expressed. Notably, these genes were related to DNA damage and repair and stress response, as well as diverse immune system responses, such as natural killer pathways including killer cell lectin-like receptors family, as well as granzymes and T-cell receptors, which play important roles in host defense. These results support the idea that sleep loss can lead to alterations in molecular processes that result in perturbation of cellular immunity, induction of inflammatory responses, and homeostatic imbalance. Moreover, expression of multiple genes was downregulated following PW and upregulated after SR compared with PW, suggesting an attempt of the body to re-establish internal homeostasis. In silico validation of alterations in the expression of CETN3, DNAJC, and CEACAM genes confirmed previous findings related to the molecular effects of sleep deprivation. Thus, the present findings confirm that the effects of sleep loss are not restricted to the brain and can occur intensely in peripheral tissues.